1.
Anti-tumor activity of cabozantinib by FAK down-regulation in human oral squamous cell carcinoma. Bangladesh J Pharmacol [Internet]. 2015 Dec. 21 [cited 2026 Jul. 2];11(1):119-25. Available from: https://www.banglajol.info/index.php/BJP/article/view/24001